Replies to post #430384 on Amarin Corp Plc (AMRN)

[JRoon71]

He basically said anything related to a new formulation is in the distant future, and they are focused on Vascepa right now.

With the U.S. market, nothing noteworthy. They don't sound too enthusiastic about an AG right now, and no mention of anything on the legal front.

[TalShu]

In Q&A They mentioned collaboration with Mochida.
Unfortunately, Mochida stopped mentioning Amarin or cooperation with it since 2021.
As to the pending Lr-EtEPA application US2024165066A1 there was no mention of it, particularly when do they expect final Grant approval.

[Birdbrain Ideas]

Actually, if I heard it right, there was talk of trying to secure smaller guaranteed markets similar to the CVS deal that fell apart. But no mention, unless I missed it, of trying to bring CVS back into the fold.

And the comments about new things that could be tried with the product made it sound like anything that might develop was in the distant future, which was a bit of a disappointment. Where does the $5 million spent on research and development each year go?